Evaluation of new apolipoprotein C-II and apolipoprotein C-III automatized immunoturbidimetric kits

Clinical Biochemistry

Volumn 39, Issue 9, 2006, Pages 935-941

  Nicolay, Alain ^a,b   Lombard, Elise ^a,b   Arlotto, Emmanuelle ^a   Saunier, Vincent ^a   Lorec Penet, Anne Marie ^a,b   Lairon, Denis ^b   Portugal, Henri ^a,b  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b INSERM   (France)

Author keywords

Apolipoprotein CII; Apolipoprotein CIII; Immunoturbidimetric kit; ISO Norm 5725 specifications; Method evaluation

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; BILIRUBIN; HEMOGLOBIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ACCURACY; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; AUTOANALYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEMOLYSIS; HUMAN; HYPERLIPIDEMIA; IMMUNOASSAY; IMMUNODIFFUSION; IMMUNOTURBIDIMETRY; INTERMETHOD COMPARISON; LIPID ANALYSIS; LIPID METABOLISM; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; RELIABILITY; SERUM; TURBIDIMETRY;

AGED; APOLIPOPROTEIN C-II; APOLIPOPROTEIN C-III; AUTOANALYSIS; AUTOMATION; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 33748530992     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.04.021     Document Type: Article

References (21)

1. Karpe F. Postprandial lipemia-effect of lipid-lowering drugs [Review]. Atheroscler Suppl 3 (2002) 41-46
2. Jong M.C., Hofker M.H., and Havekes L.M. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. [Review]. Arterioscler Thromb Vasc Biol 19 (1999) 472-484
3. Cox D.W., Breckenridge W.C., and Little J.A. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med 299 (1978) 1421-1424
4. Santamarina-Fojo S. Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotein CII. Curr Opin Lipidol 3 (1992) 186-195
5. Havel R.J., Fielding C.J., Olivecrona T., Shore V.G., Fielding P.E., and Egelrud T. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources. Biochemistry 12 (1973) 1828-1833
6. Shachter N.S., Hayek T., Leff T., et al. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. J Clin Invest 93 (1994) 1683-1690
7. Wang C.S., McConathy W.J., Kloer H.U., and Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 75 (1985) 384-390
8. Sacks F.M., Alaupovic P., Moye L.A., et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 102 (2000) 1886-1892
9. Ginsberg H.N., Jones J., Blaner W.S., et al. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 15 (1995) 1829-1838
10. Onat A., Hergenç G., Sansoy V., et al. Apolipoprotein CIII, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 168 (2003) 81-89
11. Mekki N., Christofilis M.A., Charbonnier M., et al. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J Clin Endocrinol Metab 84 (1999) 184-1891
12. Thompson G.R. Angiographic evidence for the role of triglycerides lipoproteins in progression of coronary artery disease. [Review]. Eur Heart J 19 Suppl H (1998) H31-H36
13. Blankenhorn D.H., Alaupovic P., Wickham E., Chin H.P., and Azen S.P. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 81 (1990) 470-476
14. Cohn J.S., Tremblay M., Amiot M., Bouthillier D., Roy M., Genest Jr. J., et al. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 16 (1996) 149-159
15. Vassault A., Grafmeyer D., Naudin C., et al. Protocole de validation de techniques. Ann Biol Clin 44 (1986) 686-745
16. ISO Norm 5725: Accuracy (trueness and precision) of measurement methods and results.
17. Currie L.A. Nomenclature in evaluation of analytical methods including detection and quantification capabilities (IUPAC Recommendations 1995). Anal Chim Acta 391 (1999) 105-126
18. Vassault A., Grafmeyer D., de Graeve J., Cohen R., Beaudonnet A., and Bienvenu J. Quality specifications and allowable standards for validation of methods used in clinical biochemistry. Ann Biol Clin 57 (1999) 685-695
19. Gerber Y., Goldbourt U., Cohen H., and Harats D. Association between serum apolipoprotein CII concentration and coronary heart disease. Prev Med 35 (2002) 42-47
20. Cohn J.S., Rodriguez C., Jacques H., Tremblay M., and Davignon J. Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE. J Lipid Res 45 8 (2004) 1572-1579
21. Fan P., Liu B., Fang D., and Zhang R. Serum apolipoprotein C II, C III and E levels in 437 male healthy subjects aged 40-70 in Chengdu area. Hua Xi Yi Ke Da Xue Xue Bao 28 1 (1997) 6-9